Delek US (DK) Financials

$19.77 +0.35 (+1.80%)

Closing price 05/27/2025 03:59 PM Eastern

Extended Trading

$19.78 +0.01 (+0.05%)

As of 07:17 AM Eastern

Annual Income Statements for Delek US

This table shows Delek US's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	-560	20	257	-128	-611	311	340	289	-154	19
Consolidated Net Income / (Loss)	-521	47	291	-95	-574	336	375	323	-133	44
Net Income / (Loss) Continuing Operations	-598	20	265	-95	-574	331	384	329	-220	37
Total Pre-Tax Income	-706	17	322	-137	-767	403	486	299	-391	21
Total Operating Income	-492	245	458	-35	-732	492	612	180	-49	69
Total Gross Profit	-43	549	748	251	-261	890	973	432	32	545
Total Revenue	11,852	16,467	19,801	10,648	7,302	9,298	10,233	7,267	4,198	4,782
Operating Revenue	11,852	16,467	19,801	10,648	7,302	9,298	10,233	7,267	4,198	4,782
Total Cost of Revenue	11,895	15,919	19,053	10,398	7,563	8,408	9,260	6,835	4,166	4,237
Operating Cost of Revenue	11,895	15,919	19,053	10,398	7,563	8,408	9,260	6,835	4,166	4,237
Total Operating Expenses	448	304	290	285	471	398	361	251	81	476
Selling, General & Admin Expense	253	272	314	200	235	275	248	176	106	371
Depreciation Expense	25	17	11	25	26	24	38	21	10	106
Other Operating Expenses / (Income)	-52	-2.50	-3.50	83	85	100	75	54	7.10	-0.50
Impairment Charge	244	38	0.00	0.00	126	0.00	0.00	0.00	0.00	-
Other Special Charges / (Income)	-21	-20	-31	-23	0.00	-	-	-	-42	0.00
Total Other Income / (Expense), net	-215	-228	-136	-103	-35	-90	-126	119	-342	-47
Interest & Investment Income	-221	-232	-138	18	30	46	16	17	-287	3.10
Other Income / (Expense), net	6.30	3.70	2.40	16	60	-4.10	-6.90	196	-0.40	1.60
Income Tax Expense	-108	-3.00	56	-42	-194	72	102	-29	-172	-16
Net Income / (Loss) Discontinued Operations	77	27	25	-	-	5.20	-8.70	-5.90	86	6.60
Net Income / (Loss) Attributable to Noncontrolling Interest	40	27	33	33	38	26	35	34	20	24
Basic Earnings per Share	($8.77)	$0.30	$3.63	($1.73)	($8.31)	$4.10	$4.11	$4.04	($2.49)	$0.32
Weighted Average Basic Shares Outstanding	63.88M	65.41M	70.79M	73.98M	73.60M	75.85M	82.80M	71.57M	61.92M	60.82M
Diluted Earnings per Share	($8.77)	$0.30	$3.59	($1.73)	($8.31)	$4.06	$3.95	$4.00	($2.49)	$0.32
Weighted Average Diluted Shares Outstanding	63.88M	65.41M	71.52M	73.98M	73.60M	76.57M	86.77M	72.30M	61.92M	61.32M
Weighted Average Basic & Diluted Shares Outstanding	62.51M	64.02M	66.94M	74.20M	73.78M	73.41M	78.01M	83.92M	-	-
Cash Dividends to Common per Share	$1.01	$0.93	$0.61	$0.00	$0.93	$1.14	$0.96	$0.60	$0.60	$0.60

This table shows Delek US's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-173	-414	-77	-37	-33	-165	129	-8.30	64	-119	7.40
Consolidated Net Income / (Loss)	-159	-402	-68	-26	-25	-160	136	-1.50	72	-110	17
Net Income / (Loss) Continuing Operations	-158	-412	-135	-26	-25	-177	126	-1.50	72	-135	17
Total Pre-Tax Income	-195	-465	-175	-34	-32	-221	155	-5.30	88	-186	21
Total Operating Income	-126	-416	-122	14	33	-160	212	50	143	-136	53
Total Gross Profit	-64	-210	-20	57	130	-124	278	158	237	-139	141
Total Revenue	2,642	2,161	3,042	3,422	3,228	3,719	4,629	4,196	3,924	4,034	5,325
Operating Revenue	2,642	2,161	3,042	3,422	3,228	3,719	4,629	4,196	3,924	4,034	5,325
Total Cost of Revenue	2,706	2,370	3,063	3,365	3,098	3,843	4,351	4,038	3,687	4,174	5,184
Operating Cost of Revenue	2,706	2,370	3,063	3,365	3,098	3,843	4,351	4,038	3,687	4,174	5,184
Total Operating Expenses	62	206	102	43	97	36	66	108	94	-3.90	88
Selling, General & Admin Expense	62	55	70	63	64	57	68	76	72	82	59
Depreciation Expense	6.30	-1.00	5.60	11	8.80	-0.70	4.00	6.80	6.60	-6.00	6.40
Other Operating Expenses / (Income)	-5.70	-39	17	-54	24	-38	-5.80	25	16	-49	22
Total Other Income / (Expense), net	-69	-49	-53	-47	-65	-61	-57	-55	-55	-50	-32
Interest & Investment Income	-71	-219	-54	30	22	-217	-55	26	15	-183	18
Other Income / (Expense), net	1.60	5.10	0.50	0.00	0.70	-0.90	-2.00	-0.50	7.10	-0.60	0.70
Income Tax Expense	-37	-53	-40	-7.70	-7.20	-44	29	-3.80	16	-51	4.00
Net Income / (Loss) Discontinued Operations	-0.30	-	67	-	-	-	11	-	-	-	-
Net Income / (Loss) Attributable to Noncontrolling Interest	14	12	9.30	11	7.40	4.80	7.40	6.80	7.90	9.00	9.40
Basic Earnings per Share	($2.78)	($6.48)	($1.20)	($0.58)	($0.51)	($2.51)	$1.98	($0.13)	$0.96	($1.68)	$0.11
Weighted Average Basic Shares Outstanding	62.12M	63.88M	64.06M	64.21M	64.02M	65.41M	64.89M	65.77M	66.95M	70.79M	70.47M
Diluted Earnings per Share	($2.78)	($6.48)	($1.20)	($0.58)	($0.51)	($2.49)	$1.97	($0.13)	$0.95	($1.65)	$0.10
Weighted Average Diluted Shares Outstanding	62.12M	63.88M	64.06M	64.21M	64.02M	65.41M	65.46M	65.77M	67.37M	71.52M	71.11M
Weighted Average Basic & Diluted Shares Outstanding	60.73M	62.51M	63.20M	64.54M	64.13M	64.02M	63.93M	64.82M	65.73M	66.94M	69.69M
Cash Dividends to Common per Share	$0.26	-	$0.26	$0.25	$0.25	-	$0.24	$0.23	$0.22	-	$0.40

This table details how cash moves in and out of Delek US's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-87	-19	-15	69	-168	-124	137	253	387	-142
Net Cash From Operating Activities	-67	1,014	425	371	-283	575	560	320	248	180
Net Cash From Continuing Operating Activities	-84	979	394	371	-283	575	590	322	235	144
Net Income / (Loss) Continuing Operations	-598	20	265	-95	-574	336	375	329	-220	37
Consolidated Net Income / (Loss)	-521	47	291	-95	-574	336	375	323	-133	44
Net Income / (Loss) Discontinued Operations	77	27	25	-	-	-	-	-5.90	86	6.60
Depreciation Expense	375	340	275	265	268	194	199	153	116	106
Non-Cash Adjustments To Reconcile Net Income	294	-87	167	284	2.10	101	-85	-24	366	-4.50
Changes in Operating Assets and Liabilities, net	-154	707	-314	-82	21	-56	101	-136	-32	1.30
Net Cash From Discontinued Operating Activities	17	35	32	-	-	-	-30	-2.10	13	36
Net Cash From Investing Activities	-242	-408	-932	-178	-191	-691	-125	38	201	-460
Net Cash From Continuing Investing Activities	-603	-382	-901	-178	-191	-691	-145	25	-88	-435
Purchase of Property, Plant & Equipment	-428	-393	-280	-222	-269	-413	-322	-172	-46	-188
Acquisitions	-205	-4.30	-631	-2.70	-34	-287	-1.90	185	-62	-249
Purchase of Investments	-0.40	-12	0.00	0.00	-	-	-	-	-	-
Sale of Property, Plant & Equipment	10	1.90	0.20	12	0.20	16	67	0.10	0.20	1.20
Sale and/or Maturity of Investments	5.00	15	9.90	10	72	0.80	1.20	12	20	-
Other Investing Activities, net	14	10	0.00	24	0.00	-8.00	0.00	0.00	-	-
Net Cash From Discontinued Investing Activities	362	-26	-30	-	-	-	20	12	289	-25
Net Cash From Financing Activities	222	-625	491	-124	306	-7.90	-298	-105	-62	139
Net Cash From Continuing Financing Activities	222	-625	491	-124	306	-7.90	-298	-105	-44	91
Repayment of Debt	-8,928	-5,226	-4,831	-2,755	-1,922	-1,590	-2,520	-1,350	-385	-417
Repurchase of Preferred Equity	-71	0.00	0.00	-	-	-	-	-	-	-
Repurchase of Common Equity	-42	-85	-194	0.00	-1.90	-178	-365	-25	-6.00	-42
Payment of Dividends	-64	-60	-79	0.00	-98	-87	-80	-87	-62	-58
Issuance of Debt	7,981	3,546	4,635	1,739	2,068	1,869	2,815	1,408	409	612
Issuance of Common Equity	298	0.00	3.10	0.00	0.00	0.00	-	-	-	-
Other Financing Activities, net	1,047	1,202	956	892	260	-23	-148	-51	-1.10	-2.90
Cash Interest Paid	305	329	189	125	124	126	120	82	52	49
Cash Income Taxes Paid	3.80	11	28	4.20	3.60	94	104	71	1.70	5.10

This table details how cash moves in and out of Delek US's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-112	-302	380	-96	-69	-80	80	-43	24	-313	-91
Net Cash From Operating Activities	-62	-164	-22	-48	167	91	433	95	395	-291	130
Net Cash From Continuing Operating Activities	-62	-163	-39	-48	167	87	402	95	395	-322	130
Net Income / (Loss) Continuing Operations	-158	-401	-146	-26	-25	-163	112	-1.50	72	-135	17
Consolidated Net Income / (Loss)	-159	-402	-68	-26	-25	-160	136	-1.50	72	-110	17
Net Income / (Loss) Discontinued Operations	-0.30	-1.00	-	-	-	3.20	-	-	-	-	-
Depreciation Expense	101	96	91	92	95	84	82	89	83	66	73
Non-Cash Adjustments To Reconcile Net Income	35	270	-76	-2.80	102	-8.00	74	-104	-50	45	-120
Changes in Operating Assets and Liabilities, net	-40	-128	91	-112	-5.60	174	133	111	289	-298	161
Net Cash From Discontinued Operating Activities	-0.30	-0.90	-	-	-	3.50	-	-	-	-	-
Net Cash From Investing Activities	-315	-216	78	-63	-42	-69	-59	-58	-222	-112	-99
Net Cash From Continuing Investing Activities	-315	-216	-283	-63	-42	-61	-41	-58	-222	-82	-99
Purchase of Property, Plant & Equipment	-136	-191	-104	-86	-47	-72	-43	-66	-211	-87	-95
Acquisitions	-186	-25	-178	-0.60	-0.70	-1.70	-1.30	-0.70	-0.60	-1.30	-4.40
Sale of Property, Plant & Equipment	4.30	-0.40	1.10	-	-	0.60	0.60	-	-	-1.00	0.10
Sale and/or Maturity of Investments	2.10	0.90	0.70	0.60	2.80	4.40	3.20	5.20	2.10	8.20	-
Other Investing Activities, net	0.50	-1.30	-2.50	14	3.60	8.80	1.50	4.80	-4.80	-	-
Net Cash From Discontinued Investing Activities	0.00	-	-	-	-	-8.40	-	-	-	-	-
Net Cash From Financing Activities	265	77	323	15	-194	-101	-294	-81	-149	90	-122
Net Cash From Continuing Financing Activities	265	77	323	15	-194	-101	-294	-81	-149	90	-122
Repayment of Debt	-2,554	-2,505	-2,047	-1,832	-2,544	-1,265	-1,564	-1,033	-1,366	-3,065	-380
Repurchase of Common Equity	-32	-22	-20	-	0.00	-20	-25	-40	-0.40	-90	-40
Payment of Dividends	-16	-16	-16	-6.20	-26	-15	3.90	-25	-24	-51	-28
Issuance of Debt	2,820	1,382	2,734	1,723	2,143	930	1,068	698	849	3,064	101
Issuance of Common Equity	0.00	166	-	-0.10	132	-	-	-	0.00	-	-
Other Financing Activities, net	46	1,143	-328	131	100	269	222	318	392	228	226
Cash Interest Paid	94	71	88	70	75	97	72	54	106	75	38

This table presents Delek US's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Total Assets	6,666	7,172	8,193	6,813	6,134	7,016	5,761	5,935	2,980
Total Current Assets	2,332	2,666	3,717	3,020	2,300	2,963	2,420	2,612	1,397
Cash & Equivalents	736	822	841	857	788	955	1,079	932	689
Accounts Receivable	618	784	1,234	777	528	793	514	582	266
Inventories, net	893	941	1,519	1,261	728	947	678	808	392
Other Current Assets	86	78	123	126	256	269	149	130	49
Other Current Nonoperating Assets	0.00	42	-	-	-	-	-	160	0.00
Plant, Property, & Equipment, net	2,940	2,696	2,776	2,307	2,367	2,428	2,195	2,141	1,103
Plant, Property & Equipment, gross	4,948	4,460	4,349	3,645	3,520	3,363	3,000	2,773	1,588
Accumulated Depreciation	2,008	1,764	1,573	1,338	1,152	935	805	632	484
Total Noncurrent Assets	1,394	1,810	1,700	1,486	1,467	1,625	1,145	1,183	480
Long-Term Investments	393	361	360	344	364	407	130	138	360
Goodwill	475	688	744	730	730	856	858	817	12
Intangible Assets	322	288	316	103	108	110	104	101	27
Other Noncurrent Operating Assets	204	246	280	309	266	251	53	127	81
Other Noncurrent Nonoperating Assets	0.00	228	-	-	-	-	-	-	-
Total Liabilities & Shareholders' Equity	6,666	7,172	8,193	6,813	6,134	7,016	5,761	5,935	2,980
Total Liabilities	6,091	6,212	7,123	5,799	5,009	5,181	3,953	3,971	1,797
Total Current Liabilities	2,516	2,685	3,086	3,127	1,903	2,356	1,664	2,672	935
Short-Term Debt	9.50	45	75	92	33	36	32	590	84
Accounts Payable	1,814	1,814	1,746	1,695	1,144	1,600	1,011	975	496
Other Current Liabilities	693	815	1,266	1,339	726	720	620	1,001	354
Other Current Nonoperating Liabilities	0.00	12	-	-	-	-	-	106	0.00
Total Noncurrent Liabilities	3,575	3,527	4,037	2,672	3,106	2,825	2,289	1,299	862
Long-Term Debt	2,756	2,555	2,979	2,126	2,315	2,031	1,751	875	749
Asset Retirement Reserve & Litigation Obligation	58	147	153	148	145	207	215	141	11
Noncurrent Deferred & Payable Income Tax Liabilities	215	264	267	215	256	268	210	200	76
Other Noncurrent Operating Liabilities	546	526	638	184	390	320	113	83	26
Other Noncurrent Nonoperating Liabilities	0.00	34	-	-	-	-	-	-	-
Total Equity & Noncontrolling Interests	575	960	1,070	1,014	1,125	1,835	1,808	1,964	1,183
Total Preferred & Common Equity	313	846	944	894	1,007	1,666	1,633	1,651	992
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	313	846	944	894	1,007	1,666	1,633	1,651	992
Common Stock	1,217	1,114	1,135	1,207	1,186	1,153	1,136	901	651
Retained Earnings	-206	430	508	385	522	1,206	982	768	522
Treasury Stock	-694	-694	-694	-694	-694	-692	-514	-25	-161
Accumulated Other Comprehensive Income / (Loss)	-4.10	-4.80	-5.20	-3.80	-7.20	0.10	29	6.90	-21
Noncontrolling Interest	262	114	126	120	118	169	176	314	191

This table presents Delek US's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	6,882	7,030	6,944	7,180	7,869	7,770	7,787	8,397
Total Current Assets	2,215	2,565	2,501	2,708	3,333	3,196	3,187	4,030
Cash & Equivalents	624	1,038	658	753	902	822	865	1,154
Accounts Receivable	649	562	771	832	1,167	1,004	848	1,036
Inventories, net	853	915	1,010	1,038	1,179	1,276	1,315	1,634
Other Current Assets	90	51	61	85	86	95	159	206
Plant, Property, & Equipment, net	3,187	2,829	2,786	2,804	2,835	2,869	2,882	2,678
Plant, Property & Equipment, gross	5,284	4,791	4,799	4,736	4,603	4,577	4,529	4,192
Accumulated Depreciation	2,097	1,962	2,014	1,932	1,768	1,708	1,647	1,514
Total Noncurrent Assets	1,480	1,637	1,657	1,668	1,701	1,704	1,718	1,689
Long-Term Investments	397	409	387	370	371	364	354	361
Goodwill	475	688	729	729	744	744	744	744
Intangible Assets	403	329	284	291	300	305	310	321
Other Noncurrent Operating Assets	205	212	256	277	285	291	309	264
Total Liabilities & Shareholders' Equity	6,882	7,030	6,944	7,180	7,869	7,770	7,787	8,397
Total Liabilities	6,453	6,085	5,961	6,145	6,712	6,707	6,662	7,114
Total Current Liabilities	2,592	2,467	2,565	2,607	3,003	2,915	2,870	3,829
Short-Term Debt	9.50	9.50	9.50	15	30	50	50	63
Accounts Payable	1,834	1,714	1,861	1,732	2,007	1,990	1,794	2,150
Other Current Liabilities	749	744	694	860	966	875	1,026	1,616
Total Noncurrent Liabilities	3,861	3,618	3,396	3,539	3,709	3,792	3,793	3,285
Long-Term Debt	3,026	2,780	2,452	2,482	2,609	2,761	2,726	2,671
Asset Retirement Reserve & Litigation Obligation	65	58	59	154	155	154	154	153
Noncurrent Deferred & Payable Income Tax Liabilities	191	244	262	270	304	281	284	310
Other Noncurrent Operating Liabilities	579	536	623	633	642	596	630	151
Total Equity & Noncontrolling Interests	429	875	983	1,035	1,157	1,063	1,124	1,283
Total Preferred & Common Equity	155	703	806	855	1,038	941	1,000	1,160
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	155	703	806	855	1,038	941	1,000	1,160
Common Stock	1,249	1,174	1,177	1,173	1,117	1,123	1,142	1,127
Retained Earnings	-395	229	328	382	620	518	557	732
Treasury Stock	-694	-694	-694	-694	-694	-694	-694	-694
Accumulated Other Comprehensive Income / (Loss)	-4.10	-4.80	-4.80	-4.80	-5.30	-5.30	-5.20	-4.00
Noncontrolling Interest	274	172	177	180	119	122	124	123

This table displays calculated financial ratios and metrics derived from Delek US's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-28.03%	-16.84%	85.96%	45.83%	-21.47%	-9.14%	40.81%	73.11%	-12.21%	0.00%
EBITDA Growth	-118.83%	-20.00%	199.10%	160.76%	-159.25%	-15.15%	51.83%	651.49%	-60.92%	0.00%
EBIT Growth	-295.33%	-45.99%	2,533.33%	97.19%	-237.65%	-19.31%	60.69%	859.07%	-170.55%	0.00%
NOPAT Growth	-219.08%	-23.43%	1,653.38%	95.26%	-226.68%	-16.30%	144.31%	674.59%	-128.78%	0.00%
Net Income Growth	-1,215.42%	-83.92%	404.83%	83.39%	-270.67%	-10.32%	16.21%	341.83%	-405.26%	0.00%
EPS Growth	-3,023.33%	-91.64%	307.51%	79.18%	-304.68%	2.78%	-1.25%	260.64%	-878.13%	0.00%
Operating Cash Flow Growth	-106.59%	138.33%	14.51%	231.28%	-149.18%	2.66%	75.26%	28.91%	37.78%	0.00%
Free Cash Flow Firm Growth	-138.07%	306.03%	-292.53%	190.35%	-219.69%	-39.47%	135.69%	-14.10%	0.00%	0.00%
Invested Capital Growth	2.73%	-26.32%	43.85%	-12.53%	-8.56%	6.63%	3.30%	138.65%	0.00%	0.00%
Revenue Q/Q Growth	-14.49%	-4.42%	4.91%	13.01%	-5.21%	-2.01%	-0.09%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	-163.51%	-7.94%	-18.25%	422.44%	-397.42%	-17.05%	10.16%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	-142.24%	-18.72%	-25.92%	94.78%	-119.39%	-21.65%	12.89%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	-144.77%	-6.94%	-22.80%	90.82%	-100.25%	-18.29%	-23.36%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	-86.77%	-51.91%	-26.47%	74.83%	-131.93%	-21.01%	-20.67%	0.00%	0.00%	0.00%
EPS Q/Q Growth	-83.47%	-73.68%	-29.19%	68.94%	-117.54%	-20.39%	-29.08%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-135.63%	60.38%	-51.52%	13.54%	-3.63%	-28.77%	24.93%	60.73%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	-532.88%	264.09%	-38,575.05%	-38.52%	37.53%	-52.32%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-3.35%	-14.63%	16.79%	0.82%	-14.41%	1.73%	-5.44%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	-0.36%	3.33%	3.78%	2.35%	-3.57%	9.57%	9.51%	5.94%	0.76%	11.40%
EBITDA Margin	-0.93%	3.57%	3.71%	2.31%	-5.54%	7.34%	7.86%	7.29%	1.68%	3.77%
Operating Margin	-4.15%	1.49%	2.31%	-0.33%	-10.03%	5.29%	5.98%	2.48%	-1.17%	1.44%
EBIT Margin	-4.09%	1.51%	2.32%	-0.18%	-9.20%	5.25%	5.91%	5.18%	-1.18%	1.47%
Profit (Net Income) Margin	-4.40%	0.28%	1.47%	-0.90%	-7.86%	3.62%	3.66%	4.44%	-3.18%	0.91%
Tax Burden Percent	73.78%	281.33%	90.27%	69.41%	74.77%	83.49%	77.22%	107.78%	34.10%	205.16%
Interest Burden Percent	145.51%	6.68%	69.97%	726.46%	114.20%	82.49%	80.25%	79.50%	788.71%	30.30%
Effective Tax Rate	0.00%	-18.07%	17.53%	0.00%	0.00%	17.80%	20.99%	-9.76%	0.00%	-74.18%
Return on Invested Capital (ROIC)	-15.76%	11.39%	15.23%	-1.12%	-21.09%	16.44%	20.63%	12.10%	-7.13%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-28.26%	-4.52%	9.18%	-7.53%	-27.52%	5.73%	-3.10%	211.15%	84.37%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-52.11%	-6.78%	12.65%	-7.79%	-17.68%	2.01%	-0.75%	8.41%	-15.43%	0.00%
Return on Equity (ROE)	-67.87%	4.60%	27.89%	-8.91%	-38.77%	18.46%	19.88%	20.50%	-22.56%	0.00%
Cash Return on Invested Capital (CROIC)	-18.45%	41.69%	-20.73%	12.25%	-12.14%	10.02%	17.39%	-69.79%	-207.13%	0.00%
Operating Return on Assets (OROA)	-7.01%	3.23%	6.13%	-0.29%	-10.22%	7.64%	10.35%	8.45%	-1.66%	0.00%
Return on Assets (ROA)	-7.53%	0.61%	3.87%	-1.47%	-8.73%	5.26%	6.41%	7.24%	-4.48%	0.00%
Return on Common Equity (ROCE)	-51.22%	4.06%	24.60%	-7.92%	-35.00%	16.71%	17.30%	17.22%	-18.93%	0.00%
Return on Equity Simple (ROE_SIMPLE)	-166.53%	5.52%	30.79%	-10.66%	-57.00%	20.18%	22.96%	19.54%	-13.45%	0.00%
Net Operating Profit after Tax (NOPAT)	-344	289	377	-24	-513	405	483	198	-34	120
NOPAT Margin	-2.90%	1.75%	1.91%	-0.23%	-7.02%	4.35%	4.72%	2.72%	-0.82%	2.50%
Net Nonoperating Expense Percent (NNEP)	12.50%	15.90%	6.05%	6.41%	6.44%	10.71%	23.72%	-199.06%	-91.50%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	-10.30%	8.12%	9.15%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	100.36%	96.67%	96.22%	97.65%	103.57%	90.43%	90.49%	94.06%	99.24%	88.60%
SG&A Expenses to Revenue	2.13%	1.65%	1.58%	1.88%	3.21%	2.95%	2.42%	2.42%	2.53%	7.76%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	3.78%	1.84%	1.47%	2.68%	6.45%	4.28%	3.53%	3.46%	1.93%	9.96%
Earnings before Interest and Taxes (EBIT)	-485	248	460	-19	-672	488	605	377	-50	70
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-111	588	735	246	-404	683	804	530	71	180
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.74	1.86	1.84	1.14	1.08	1.30	1.37	1.42	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	16.42	6.40	3.09	3.34	3.19	0.00	0.00
Price to Revenue (P/Rev)	0.10	0.10	0.09	0.10	0.15	0.23	0.22	0.32	0.00	0.00
Price to Earnings (P/E)	0.00	79.62	6.74	0.00	0.00	6.96	6.58	8.10	0.00	0.00
Dividend Yield	5.43%	3.75%	2.45%	0.00%	8.38%	3.92%	3.52%	2.09%	3.11%	3.68%
Earnings Yield	0.00%	1.26%	14.84%	0.00%	0.00%	14.38%	15.20%	12.35%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.39	1.44	1.27	1.06	1.03	1.19	1.25	1.32	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.26	0.19	0.19	0.20	0.33	0.33	0.29	0.42	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	5.29	5.05	8.76	0.00	4.45	3.71	5.75	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	12.51	8.07	0.00	0.00	6.21	4.94	8.10	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	10.76	9.83	0.00	0.00	7.50	6.18	15.40	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	3.07	8.73	5.80	0.00	5.27	5.33	9.53	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	2.94	0.00	8.07	0.00	12.30	7.33	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	4.81	2.71	2.86	2.19	2.09	1.13	0.99	0.75	0.70	0.00
Long-Term Debt to Equity	4.79	2.66	2.79	2.10	2.06	1.11	0.97	0.45	0.63	0.00
Financial Leverage	1.84	1.50	1.38	1.04	0.64	0.35	0.24	0.04	-0.18	0.00
Leverage Ratio	9.02	7.57	7.20	6.05	4.44	3.51	3.10	2.83	2.52	0.00
Compound Leverage Factor	13.12	0.51	5.04	43.97	5.07	2.89	2.49	2.25	19.87	0.00
Debt to Total Capital	82.78%	73.04%	74.06%	68.63%	67.61%	52.97%	49.65%	42.73%	41.33%	0.00%
Short-Term Debt to Total Capital	0.28%	1.25%	1.81%	2.85%	0.96%	0.93%	0.89%	17.21%	4.19%	0.00%
Long-Term Debt to Total Capital	82.50%	71.79%	72.25%	65.77%	66.65%	52.04%	48.76%	25.52%	37.14%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	7.86%	3.21%	3.05%	3.71%	3.41%	4.33%	4.89%	9.14%	9.46%	0.00%
Common Equity to Total Capital	9.36%	23.75%	22.89%	27.67%	28.98%	42.70%	45.46%	48.13%	49.22%	0.00%
Debt to EBITDA	-24.98	4.42	4.16	9.03	-5.81	3.03	2.22	2.77	11.81	0.00
Net Debt to EBITDA	-14.79	2.41	2.52	4.14	-2.96	1.03	0.71	0.75	-3.07	0.00
Long-Term Debt to EBITDA	-24.89	4.35	4.05	8.65	-5.72	2.98	2.18	1.65	10.62	0.00
Debt to NOPAT	-8.04	9.00	8.09	-91.31	-4.58	5.11	3.69	7.41	-24.18	0.00
Net Debt to NOPAT	-4.76	4.91	4.91	-41.89	-2.34	1.74	1.19	2.00	6.28	0.00
Long-Term Debt to NOPAT	-8.01	8.84	7.90	-87.52	-4.52	5.02	3.62	4.42	-21.73	0.00
Altman Z-Score	1.58	2.64	2.93	1.72	1.16	2.15	2.86	1.96	0.00	0.00
Noncontrolling Interest Sharing Ratio	24.54%	11.83%	11.79%	11.14%	9.71%	9.46%	12.97%	16.02%	16.12%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.93	0.99	1.20	0.97	1.21	1.26	1.45	0.98	1.49	0.00
Quick Ratio	0.54	0.60	0.67	0.52	0.69	0.74	0.96	0.57	1.02	0.00
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-403	1,058	-513	267	-295	247	407	-1,142	-1,001	0.00
Operating Cash Flow to CapEx	-16.00%	259.50%	151.89%	176.60%	-105.09%	144.96%	219.38%	185.98%	537.96%	96.51%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	1.95	-2.35	1.88	3.02	-12.17	-18.39	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	2.72	-2.25	4.39	4.15	3.41	4.56	3.45
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	1.18	-4.39	1.36	2.26	1.58	3.71	-0.12
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.71	2.14	2.64	1.64	1.11	1.46	1.75	1.63	1.41	0.00
Accounts Receivable Turnover	16.92	16.32	19.69	16.33	11.06	14.23	18.67	17.15	15.78	0.00
Inventory Turnover	12.97	12.94	13.71	10.46	9.03	10.35	12.46	11.38	10.62	0.00
Fixed Asset Turnover	4.21	6.02	7.79	4.56	3.05	4.02	4.72	4.48	3.80	0.00
Accounts Payable Turnover	6.56	8.94	11.07	7.32	5.51	6.44	9.32	9.29	8.39	0.00
Days Sales Outstanding (DSO)	21.58	22.37	18.53	22.36	33.00	25.65	19.55	21.29	23.13	0.00
Days Inventory Outstanding (DIO)	28.14	28.20	26.62	34.90	40.41	35.26	29.29	32.06	34.38	0.00
Days Payable Outstanding (DPO)	55.66	40.81	32.96	49.84	66.21	56.67	39.15	39.29	43.49	0.00
Cash Conversion Cycle (CCC)	-5.94	9.75	12.20	7.42	7.20	4.25	9.69	14.06	14.02	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,212	2,153	2,922	2,031	2,322	2,540	2,382	2,306	966	0.00
Invested Capital Turnover	5.43	6.49	7.99	4.89	3.00	3.78	4.37	4.44	8.69	0.00
Increase / (Decrease) in Invested Capital	59	-769	891	-291	-217	158	76	1,340	966	0.00
Enterprise Value (EV)	3,068	3,108	3,711	2,152	2,398	3,034	2,987	3,048	0.00	0.00
Market Capitalization	1,169	1,577	1,732	1,015	1,082	2,160	2,238	2,339	0.00	0.00
Book Value per Share	$4.95	$13.22	$13.54	$12.06	$13.65	$22.45	$19.92	$20.26	$16.02	$0.00
Tangible Book Value per Share	($7.66)	($2.03)	($1.67)	$0.83	$2.30	$9.43	$8.18	$9.00	$15.39	$0.00
Total Capital	3,340	3,560	4,123	3,232	3,474	3,902	3,591	3,430	2,015	0.00
Total Debt	2,765	2,600	3,054	2,218	2,348	2,067	1,783	1,466	833	0.00
Total Long-Term Debt	2,756	2,555	2,979	2,126	2,315	2,031	1,751	875	749	0.00
Net Debt	1,637	1,417	1,853	1,017	1,197	705	574	396	-216	0.00
Capital Expenditures (CapEx)	418	391	280	210	269	397	255	172	46	187
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-910	-796	-136	-871	-358	-312	-291	-402	-143	0.00
Debt-free Net Working Capital (DFNWC)	-175	25	705	-15	430	644	789	530	546	0.00
Net Working Capital (NWC)	-184	-19	631	-107	396	607	757	-60	462	0.00
Net Nonoperating Expense (NNE)	177	242	87	71	61	68	109	-125	99	76
Net Nonoperating Obligations (NNO)	1,637	1,194	1,853	1,017	1,197	705	574	342	-216	0.00
Total Depreciation and Amortization (D&A)	375	340	275	265	268	194	199	153	120	110
Debt-free, Cash-free Net Working Capital to Revenue	-7.68%	-4.84%	-0.69%	-8.18%	-4.90%	-3.35%	-2.84%	-5.52%	-3.41%	0.00%
Debt-free Net Working Capital to Revenue	-1.47%	0.15%	3.56%	-0.14%	5.88%	6.92%	7.71%	7.30%	13.01%	0.00%
Net Working Capital to Revenue	-1.55%	-0.12%	3.18%	-1.00%	5.43%	6.53%	7.40%	-0.82%	11.00%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($8.77)	$0.30	$3.63	($2.75)	($8.26)	$4.10	$0.00	$4.04	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	63.88M	65.41M	70.79M	73.98M	73.60M	75.85M	0.00	71.57M	0.00	0.00
Adjusted Diluted Earnings per Share	($8.77)	$0.30	$3.59	($2.75)	($8.26)	$4.06	$0.00	$4.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	63.88M	65.98M	71.52M	73.98M	73.60M	76.57M	0.00	72.30M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	62.51M	64.02M	66.94M	74.20M	73.78M	73.41M	0.00	83.92M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-188	184	352	-41	-424	405	483	126	-64	48
Normalized NOPAT Margin	-1.59%	1.12%	1.78%	-0.38%	-5.81%	4.35%	4.72%	1.74%	-1.53%	1.01%
Pre Tax Income Margin	-5.96%	0.10%	1.63%	-1.29%	-10.51%	4.33%	4.74%	4.12%	-9.32%	0.45%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	-0.14	-5.35	3.72	4.48	4.01	-0.91	1.35
NOPAT to Interest Expense	0.00	0.00	0.00	-0.18	-4.08	3.09	3.58	2.11	-0.63	2.30
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	-1.68	-7.49	0.70	2.59	2.18	-1.76	-2.23
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	-1.72	-6.22	0.06	1.69	0.28	-1.48	-1.28
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-12.32%	129.12%	27.13%	0.00%	-17.08%	25.82%	21.37%	26.97%	-46.18%	132.72%
Augmented Payout Ratio	-20.29%	311.99%	93.77%	0.00%	-17.41%	78.79%	118.81%	34.72%	-50.67%	229.29%

This table displays calculated financial ratios and metrics derived from Delek US's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-15.54%	-41.90%	-34.27%	-18.45%	-17.75%	-7.83%	-13.07%	-29.87%	-11.99%	29.81%	80.11%
EBITDA Growth	-118.85%	-308.84%	-110.43%	-24.03%	-44.88%	-9.39%	131.04%	-75.39%	105.19%	-174.95%	5.06%
EBIT Growth	-516.78%	-154.78%	-157.78%	-72.78%	-77.72%	-18.44%	291.25%	-90.02%	230.18%	-648.79%	-10.05%
NOPAT Growth	-530.82%	-159.39%	-149.55%	-73.05%	-80.46%	-18.30%	302.27%	-90.95%	203.43%	-642.00%	37.62%
Net Income Growth	-528.97%	-151.16%	-149.60%	-1,640.00%	-134.90%	-45.94%	710.12%	-100.41%	387.84%	-2,050.98%	-18.45%
EPS Growth	-445.10%	-160.24%	-160.91%	-346.15%	-153.68%	-50.91%	1,870.00%	-102.57%	955.56%	-870.59%	-37.50%
Operating Cash Flow Growth	-137.43%	-280.07%	-104.99%	-150.89%	-57.81%	131.22%	232.26%	-82.99%	1,374.25%	-280.40%	72.91%
Free Cash Flow Firm Growth	-142.38%	-153.25%	-2.65%	405.80%	151.04%	166.64%	134.26%	41.00%	-295.04%	-419.50%	-160.94%
Invested Capital Growth	1.49%	2.73%	-9.26%	-10.74%	-10.14%	-26.32%	0.80%	5.19%	34.98%	43.85%	24.19%
Revenue Q/Q Growth	22.28%	-28.99%	-11.09%	6.01%	-20.29%	-19.67%	10.33%	6.91%	-12.39%	-24.24%	-10.99%
EBITDA Q/Q Growth	92.72%	-930.82%	-128.88%	-17.88%	351.66%	-126.29%	110.43%	-40.42%	990.46%	-155.53%	-77.59%
EBIT Q/Q Growth	69.76%	-238.30%	-999.26%	-59.58%	124.10%	-176.73%	323.59%	-66.91%	244.13%	-353.45%	-89.19%
NOPAT Q/Q Growth	69.75%	-241.10%	-1,002.96%	-58.72%	123.75%	-165.16%	391.03%	-70.07%	261.71%	-321.57%	-88.96%
Net Income Q/Q Growth	60.58%	-495.70%	-158.62%	-3.57%	84.26%	-217.63%	9,173.33%	-102.08%	165.82%	-752.98%	-95.44%
EPS Q/Q Growth	57.10%	-440.00%	-106.90%	-13.73%	79.52%	-226.40%	1,615.38%	-113.68%	157.58%	-1,750.00%	-98.02%
Operating Cash Flow Q/Q Growth	61.83%	-656.94%	55.37%	-129.03%	83.59%	-79.01%	354.89%	-75.93%	235.87%	-323.35%	-76.71%
Free Cash Flow Firm Q/Q Growth	64.59%	-335.89%	-50.29%	1.21%	-34.40%	331.24%	256.16%	83.11%	40.06%	-121.70%	-168.96%
Invested Capital Q/Q Growth	10.50%	-3.35%	-4.63%	-0.36%	1.33%	-14.63%	-6.19%	0.31%	-8.28%	16.79%	-2.10%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	-2.41%	-9.70%	-0.66%	1.65%	4.03%	-3.34%	6.01%	3.76%	6.04%	-3.46%	2.65%
EBITDA Margin	-0.87%	-14.55%	-1.00%	3.09%	3.98%	-2.07%	6.32%	3.31%	5.95%	-1.74%	2.38%
Operating Margin	-4.76%	-19.25%	-4.01%	0.39%	1.01%	-4.31%	4.58%	1.19%	3.64%	-3.36%	1.00%
EBIT Margin	-4.70%	-19.01%	-3.99%	0.39%	1.03%	-4.34%	4.54%	1.18%	3.82%	-3.37%	1.01%
Profit (Net Income) Margin	-6.00%	-18.61%	-2.22%	-0.76%	-0.78%	-4.31%	2.94%	-0.04%	1.84%	-2.72%	0.32%
Tax Burden Percent	81.28%	86.53%	38.55%	77.22%	77.78%	72.51%	87.98%	28.30%	82.05%	59.01%	80.77%
Interest Burden Percent	157.00%	113.15%	144.23%	-250.37%	-97.01%	136.97%	73.63%	-10.69%	58.71%	136.59%	38.73%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	18.81%	0.00%	17.95%	0.00%	19.23%
Return on Invested Capital (ROIC)	-15.62%	-73.16%	-16.16%	1.68%	4.52%	-19.58%	25.51%	5.71%	25.23%	-18.80%	6.72%
ROIC Less NNEP Spread (ROIC-NNEP)	-19.77%	-81.01%	-14.85%	-0.66%	1.24%	-22.73%	22.72%	3.14%	21.72%	-19.83%	4.41%
Return on Net Nonoperating Assets (RNNOA)	-45.74%	-149.37%	-19.12%	-0.98%	1.68%	-34.12%	24.06%	3.72%	26.56%	-27.32%	4.41%
Return on Equity (ROE)	-61.36%	-222.52%	-35.28%	0.70%	6.20%	-53.70%	49.58%	9.44%	51.79%	-46.11%	11.12%
Cash Return on Invested Capital (CROIC)	-20.13%	-18.45%	3.87%	15.02%	15.35%	41.69%	11.57%	-1.26%	-9.20%	-20.73%	0.06%
Operating Return on Assets (OROA)	-7.60%	-32.56%	-7.42%	0.83%	2.24%	-9.29%	9.61%	2.54%	9.57%	-8.90%	2.51%
Return on Assets (ROA)	-9.70%	-31.88%	-4.13%	-1.60%	-1.69%	-9.23%	6.23%	-0.08%	4.61%	-7.18%	0.79%
Return on Common Equity (ROCE)	-42.34%	-167.93%	-29.22%	0.59%	5.33%	-47.34%	44.66%	8.48%	45.65%	-40.67%	9.93%
Return on Equity Simple (ROE_SIMPLE)	-420.98%	0.00%	-39.67%	-9.34%	-5.93%	0.00%	9.36%	-2.36%	34.79%	0.00%	34.05%
Net Operating Profit after Tax (NOPAT)	-88	-291	-85	9.45	23	-112	172	35	117	-95	43
NOPAT Margin	-3.33%	-13.47%	-2.80%	0.28%	0.71%	-3.02%	3.72%	0.84%	2.99%	-2.35%	0.80%
Net Nonoperating Expense Percent (NNEP)	4.16%	7.85%	-1.32%	2.34%	3.28%	3.14%	2.79%	2.57%	3.50%	1.03%	2.31%
Return On Investment Capital (ROIC_SIMPLE)	-2.54%	-8.71%	-	-	-	-3.15%	-	-	-	-2.30%	-
Cost of Revenue to Revenue	102.41%	109.70%	100.66%	98.35%	95.97%	103.34%	93.99%	96.24%	93.96%	103.46%	97.35%
SG&A Expenses to Revenue	2.33%	2.54%	2.31%	1.84%	2.00%	1.53%	1.46%	1.81%	1.82%	2.03%	1.11%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	2.35%	9.55%	3.34%	1.26%	3.02%	0.97%	1.42%	2.56%	2.40%	-0.10%	1.65%
Earnings before Interest and Taxes (EBIT)	-124	-411	-121	14	33	-161	210	50	150	-136	54
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-23	-314	-31	106	129	-77	293	139	233	-70	127
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.06	3.74	1.72	1.95	2.25	1.86	1.70	1.59	1.45	1.84	1.54
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	18.65
Price to Revenue (P/Rev)	0.08	0.10	0.09	0.10	0.12	0.10	0.10	0.08	0.07	0.09	0.09
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	79.62	26.78	0.00	4.60	6.74	4.93
Dividend Yield	6.74%	5.43%	5.28%	3.97%	3.89%	3.75%	4.02%	4.65%	3.84%	2.45%	1.59%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	1.26%	3.73%	0.00%	21.76%	14.84%	20.26%
Enterprise Value to Invested Capital (EV/IC)	1.32	1.39	1.22	1.32	1.44	1.44	1.29	1.21	1.17	1.27	1.25
Enterprise Value to Revenue (EV/Rev)	0.28	0.26	0.20	0.20	0.21	0.19	0.19	0.18	0.16	0.19	0.17
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	16.04	6.36	6.55	5.29	5.09	6.87	3.48	5.05	3.48
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	24.10	20.78	12.51	10.64	21.75	5.24	8.07	5.04
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	33.91	29.25	10.76	10.47	32.56	6.52	9.83	6.40
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	14.91	4.93	4.43	3.07	5.15	9.85	3.94	8.73	3.57
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	30.05	8.28	8.90	2.94	11.19	0.00	0.00	0.00	2,345.50
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	7.07	4.81	2.95	2.50	2.41	2.71	2.28	2.64	2.47	2.86	2.13
Long-Term Debt to Equity	7.05	4.79	2.94	2.50	2.40	2.66	2.25	2.60	2.42	2.79	2.08
Financial Leverage	2.31	1.84	1.29	1.49	1.36	1.50	1.06	1.18	1.22	1.38	1.00
Leverage Ratio	9.60	9.02	7.09	7.19	6.93	7.57	6.67	6.96	7.50	7.20	6.71
Compound Leverage Factor	15.08	10.20	10.22	-18.01	-6.72	10.37	4.91	-0.74	4.40	9.84	2.60
Debt to Total Capital	87.61%	82.78%	74.69%	71.47%	70.69%	73.04%	69.51%	72.56%	71.17%	74.06%	68.06%
Short-Term Debt to Total Capital	0.27%	0.28%	0.25%	0.28%	0.41%	1.25%	0.78%	1.28%	1.27%	1.81%	1.57%
Long-Term Debt to Total Capital	87.33%	82.50%	74.43%	71.19%	70.28%	71.79%	68.74%	71.28%	69.90%	72.25%	66.49%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	7.91%	7.86%	6.49%	5.14%	5.09%	3.21%	3.14%	3.14%	3.19%	3.05%	3.05%
Common Equity to Total Capital	4.49%	9.36%	18.83%	23.39%	24.21%	23.75%	27.34%	24.30%	25.65%	22.89%	28.89%
Debt to EBITDA	-11.90	-24.98	16.00	4.95	4.70	4.42	4.13	5.95	3.09	4.16	3.04
Net Debt to EBITDA	-7.90	-14.79	7.71	2.85	2.59	2.41	2.14	3.44	1.73	2.52	1.36
Long-Term Debt to EBITDA	-11.86	-24.89	15.95	4.93	4.68	4.35	4.08	5.84	3.03	4.05	2.97
Debt to NOPAT	-6.71	-8.04	-19.84	26.40	21.01	9.00	8.50	28.20	5.78	8.09	5.59
Net Debt to NOPAT	-4.45	-4.76	-9.56	15.20	11.55	4.91	4.40	16.31	3.24	4.91	2.49
Long-Term Debt to NOPAT	-6.69	-8.01	-19.78	26.30	20.89	8.84	8.40	27.70	5.68	7.90	5.46
Altman Z-Score	1.53	1.61	2.10	2.44	2.55	2.45	2.60	2.60	2.87	2.69	2.57
Noncontrolling Interest Sharing Ratio	30.99%	24.54%	17.20%	14.60%	14.09%	11.83%	9.92%	10.17%	11.85%	11.79%	10.69%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.85	0.93	1.04	0.98	1.04	0.99	1.11	1.10	1.11	1.20	1.05
Quick Ratio	0.49	0.54	0.65	0.56	0.61	0.60	0.69	0.63	0.60	0.67	0.57
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-124	-350	148	298	295	657	152	-98	-577	-986	-445
Operating Cash Flow to CapEx	-47.49%	-85.65%	-21.01%	-56.28%	352.43%	126.82%	1,027.55%	143.44%	186.99%	-328.96%	137.63%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	3.84	3.36	0.00	0.00	-1.21	-7.55	0.00	-8.77
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	-0.62	1.90	0.00	0.00	1.18	5.16	0.00	2.57
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	-1.73	1.36	0.00	0.00	0.36	2.40	0.00	0.70
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.62	1.71	1.86	2.10	2.17	2.14	2.12	2.15	2.51	2.64	2.49
Accounts Receivable Turnover	15.35	16.92	16.04	17.41	19.32	16.32	15.64	15.43	17.50	19.69	18.47
Inventory Turnover	12.24	12.97	13.04	13.07	13.28	12.94	11.75	11.27	12.70	13.71	13.14
Fixed Asset Turnover	3.79	4.21	4.89	5.46	5.71	6.02	6.25	6.48	7.65	7.79	7.56
Accounts Payable Turnover	6.49	6.56	7.34	7.76	8.86	8.94	7.95	7.82	8.60	11.07	9.35
Days Sales Outstanding (DSO)	23.77	21.58	22.76	20.97	18.90	22.37	23.33	23.65	20.86	18.53	19.76
Days Inventory Outstanding (DIO)	29.82	28.14	27.99	27.93	27.49	28.20	31.05	32.39	28.73	26.62	27.77
Days Payable Outstanding (DPO)	56.26	55.66	49.72	47.04	41.21	40.81	45.88	46.65	42.45	32.96	39.04
Cash Conversion Cycle (CCC)	-2.67	-5.94	1.02	1.86	5.18	9.75	8.50	9.39	7.14	12.20	8.48
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,444	2,212	2,289	2,400	2,408	2,153	2,522	2,689	2,680	2,922	2,502
Invested Capital Turnover	4.68	5.43	5.76	6.07	6.38	6.49	6.86	6.84	8.45	7.99	8.36
Increase / (Decrease) in Invested Capital	36	59	-234	-289	-272	-769	20	133	695	891	487
Enterprise Value (EV)	3,231	3,068	2,795	3,162	3,477	3,108	3,252	3,245	3,127	3,711	3,130
Market Capitalization	942	1,169	1,210	1,568	1,924	1,577	1,767	1,498	1,447	1,732	1,788
Book Value per Share	$2.49	$4.95	$10.89	$12.56	$13.36	$13.22	$16.01	$14.32	$14.94	$13.54	$16.33
Tangible Book Value per Share	($11.56)	($7.66)	($4.85)	($3.24)	($2.58)	($2.03)	($0.11)	($1.64)	($0.82)	($1.67)	$1.35
Total Capital	3,465	3,340	3,735	3,445	3,532	3,560	3,795	3,874	3,899	4,123	4,017
Total Debt	3,035	2,765	2,789	2,462	2,497	2,600	2,638	2,811	2,775	3,054	2,734
Total Long-Term Debt	3,026	2,756	2,780	2,452	2,482	2,555	2,609	2,761	2,726	2,979	2,671
Net Debt	2,015	1,637	1,343	1,417	1,373	1,417	1,365	1,626	1,556	1,853	1,219
Capital Expenditures (CapEx)	131	191	103	86	47	72	42	66	211	88	95
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-991	-910	-930	-712	-637	-796	-542	-491	-499	-136	-891
Debt-free Net Working Capital (DFNWC)	-368	-175	107	-54	116	25	360	331	367	705	263
Net Working Capital (NWC)	-377	-184	98	-64	102	-19	331	282	317	631	200
Net Nonoperating Expense (NNE)	70	111	-18	36	48	48	36	37	45	15	26
Net Nonoperating Obligations (NNO)	2,015	1,637	1,343	1,417	1,373	1,194	1,365	1,626	1,556	1,853	1,219
Total Depreciation and Amortization (D&A)	101	96	91	92	95	84	82	89	83	66	73
Debt-free, Cash-free Net Working Capital to Revenue	-8.72%	-7.68%	-6.71%	-4.61%	-3.93%	-4.84%	-3.14%	-2.74%	-2.53%	-0.69%	-4.72%
Debt-free Net Working Capital to Revenue	-3.23%	-1.47%	0.77%	-0.35%	0.72%	0.15%	2.09%	1.85%	1.86%	3.56%	1.39%
Net Working Capital to Revenue	-3.32%	-1.55%	0.71%	-0.41%	0.63%	-0.12%	1.92%	1.57%	1.61%	3.18%	1.06%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($2.78)	($6.48)	($1.20)	($0.58)	($0.51)	($2.51)	$1.98	($0.13)	$0.96	($1.68)	$0.11
Adjusted Weighted Average Basic Shares Outstanding	62.12M	63.88M	64.06M	64.21M	64.02M	65.41M	64.89M	65.77M	66.95M	70.79M	69.69M
Adjusted Diluted Earnings per Share	($2.78)	($6.48)	($1.20)	($0.58)	($0.51)	($2.49)	$1.97	($0.13)	$0.95	($1.65)	$0.10
Adjusted Weighted Average Diluted Shares Outstanding	62.12M	63.88M	64.06M	64.21M	64.02M	65.41M	65.46M	65.77M	67.37M	71.52M	69.69M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	60.73M	62.51M	63.20M	64.54M	64.13M	64.02M	63.93M	64.82M	65.73M	66.94M	69.69M
Normalized Net Operating Profit after Tax (NOPAT)	-88	-291	-79	25	23	-112	172	35	117	-95	43
Normalized NOPAT Margin	-3.33%	-13.47%	-2.59%	0.73%	0.71%	-3.02%	3.72%	0.84%	2.99%	-2.35%	0.80%
Pre Tax Income Margin	-7.38%	-21.51%	-5.76%	-0.99%	-1.00%	-5.94%	3.34%	-0.13%	2.24%	-4.61%	0.39%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.17	0.38	0.00	0.00	0.62	1.96	0.00	1.06
NOPAT to Interest Expense	0.00	0.00	0.00	0.12	0.26	0.00	0.00	0.44	1.53	0.00	0.84
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	-0.93	-0.16	0.00	0.00	-0.21	-0.80	0.00	-0.81
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	-0.99	-0.28	0.00	0.00	-0.39	-1.23	0.00	-1.02
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-9.84%	-12.32%	-22.77%	-57.37%	-121.50%	129.12%	98.25%	-574.77%	27.11%	27.13%	7.16%
Augmented Payout Ratio	-21.00%	-20.29%	-37.11%	-117.13%	-289.15%	311.99%	257.88%	-1,340.54%	64.47%	93.77%	33.49%

Frequently Asked Questions About Delek US's Financials

When does Delek US's financial year end?

According to the most recent income statement we have on file, Delek US's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Delek US's net income changed over the last 9 years?

Delek US's net income appears to be on a downward trend, with a most recent value of -$520.90 million in 2024, falling from $43.70 million in 2015. The previous period was $46.70 million in 2023. Check out Delek US's forecast to explore projected trends and price targets.

What is Delek US's operating income?

Delek US's total operating income in 2024 was -$491.50 million, based on the following breakdown:

Total Gross Profit: -$43.10 million
Total Operating Expenses: $448.40 million

How has Delek US revenue changed over the last 9 years?

Over the last 9 years, Delek US's total revenue changed from $4.78 billion in 2015 to $11.85 billion in 2024, a change of 147.9%.

How much debt does Delek US have?

Delek US's total liabilities were at $6.09 billion at the end of 2024, a 2.0% decrease from 2023, and a 238.9% increase since 2016.

How much cash does Delek US have?

In the past 8 years, Delek US's cash and equivalents has ranged from $689.20 million in 2016 to $1.08 billion in 2018, and is currently $735.60 million as of their latest financial filing in 2024.

How has Delek US's book value per share changed over the last 9 years?

Over the last 9 years, Delek US's book value per share changed from 0.00 in 2015 to 4.95 in 2024, a change of 495.0%.

Related Companies

This page (NYSE:DK) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Delek US (DK) Financials

Frequently Asked Questions About Delek US's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Delek US (DK) Financials

Annual Income Statements for Delek US

Quarterly Income Statements for Delek US

Annual Cash Flow Statements for Delek US

Quarterly Cash Flow Statements for Delek US

Annual Balance Sheets for Delek US

Quarterly Balance Sheets for Delek US

Annual Metrics And Ratios for Delek US

Quarterly Metrics And Ratios for Delek US

Frequently Asked Questions About Delek US's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools